Target intelligence / Profile preview

PRAME family member 28, pseudogene (PRAMEF28P)

Target: PRAMEF28P
Molecular classification: Other (pseudogene)

Overview

PRAME family member 28, pseudogene (PRAMEF28P), is a non-coding DNA sequence classified as a pseudogene based on its sequence similarity to functional PRAME family genes but inability to encode a functional protein[5][7]. Pseudogenes like PRAMEF28P typically arise from gene duplication, retrotransposition, or mutation events that disable normal gene expression and translation[1][2][6][8]. While pseudogenes were originally considered nonfunctional genomic remnants, research has shown that some pseudogenes can regulate the expression of parent genes via RNA-based mechanisms or by serving as miRNA decoys[1][2]. Despite this, PRAMEF28P itself has not been directly implicated in any regulatory, structural, or disease-associated functions, and is not currently considered a therapeutic target[5][7].

Other names: PRAMEF28PRAMEF28P

Biological functions

Pseudogenes generally do not encode proteins but can participate in gene regulation via RNA interference and other non-coding RNA regulatory processes, and may affect mRNA stability of functional genes through competitive mechanisms.PRAMEF28P specifically has not been characterized with a biological function, so its functions remain undetermined.

Disease associations

Although some pseudogenes play indirect roles in gene regulation related to cancer, metabolic disease, or gene network modulation.PRAMEF28P has not been specifically associated with any disease roles.

Beyond the preview

Go deeper on PRAME family member 28, pseudogene (PRAMEF28P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRAME family member 28, pseudogene (PRAMEF28P).

Explore the full profile